Patents by Inventor Rong Feng

Rong Feng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190148599
    Abstract: An optoelectronic device includes a semiconductor stack including a first surface and a second surface opposite to the first surface; a first contact layer on the first surface; and a second contact layer on the second surface. The second contact layer is not overlapped with the first contact layer in a vertical direction. The second contact layer includes a plurality of dots separating to each other and formed of semiconductor material.
    Type: Application
    Filed: December 20, 2018
    Publication date: May 16, 2019
    Inventors: Chun-Yu LIN, Yung-Fu CHANG, Rong-Ren LEE, Kuo-Feng HUANG, Cheng-Long YEH, Yi-Ching LEE, Ming-Siang HUANG, Ming-Tzung LIOU
  • Publication number: 20190147629
    Abstract: A focus detection apparatus and a method thereof are provided. In the method, a medical image is obtained. Size of a target focus and a sliding window are determined, and side length of the sliding windows is at least twice the side length of the target focus. The medical image is scanned through the sliding window, and a stride which the sliding windows moves each time is not greater than the side length of the target focus. At least one area of interest is obtained based on the scan result. Then, the area of interest is identified based on machine learning techniques, and perform candidate aggregation and multiple size aggregation to determine at least one focus position. Accordingly, the computational time and the detection accuracy can be improved.
    Type: Application
    Filed: October 25, 2018
    Publication date: May 16, 2019
    Applicant: TAIHAO MEDICAL INC.
    Inventors: Ruey-Feng Chang, Jen-Feng Hsu, Hong-Hao Chen, Rong-Tai Chen, Tsung-Chen Chiang, You-Wei Wang, Hsin-Hung Lai
  • Patent number: 10232011
    Abstract: The invention provides low-dose formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative.
    Type: Grant
    Filed: March 19, 2018
    Date of Patent: March 19, 2019
    Assignee: SYNERGY PHARMACEUTICALS, INC.
    Inventors: Stephen Comiskey, Rong Feng, John Foss, Kunwar Shailubhai
  • Publication number: 20190002501
    Abstract: The invention provides processes of purifying a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-251 described herein. The processes include a solvent exchange step before a freeze-drying (lyophilization) step.
    Type: Application
    Filed: June 5, 2018
    Publication date: January 3, 2019
    Inventors: Kunwar Shailubhai, Stephen Comiskey, Rong Feng, Juncai Bai, Ruoping Zhang, Jun Jia, Junfeng Zhou, Qiao Zhao, Guoqing Zhang
  • Publication number: 20180207229
    Abstract: The invention provides low-dose formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative.
    Type: Application
    Filed: March 19, 2018
    Publication date: July 26, 2018
    Inventors: Stephen COMISKEY, Rong FENG, John FOSS, Kunwar SHAILUBHAI
  • Patent number: 10011637
    Abstract: The invention provides processes of purifying a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-251 described herein. The processes include a solvent exchange step before a freeze-drying (lyophilization) step.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: July 3, 2018
    Assignee: SYNERGY PHARMACEUTICALS, INC.
    Inventors: Kunwar Shailubhai, Stephen Comiskey, Rong Feng, Juncai Bai, Ruoping Zhang, Jun Jia, Junfeng Zhou, Qiao Zhao, Guoqing Zhang
  • Patent number: 9925231
    Abstract: The invention provides low-dose formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: March 27, 2018
    Assignee: SYNERGY PHARMACEUTICALS, INC.
    Inventors: Stephen Comiskey, Rong Feng, John Foss, Kunwar Shailubhai
  • Patent number: 9919024
    Abstract: The invention provides low-dose formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: March 20, 2018
    Assignee: SYNERGY PHARMACEUTICALS, INC.
    Inventors: Stephen Comiskey, Rong Feng, John Foss, Kunwar Shailubhai
  • Publication number: 20170202904
    Abstract: The invention provides low-dose formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative.
    Type: Application
    Filed: March 23, 2017
    Publication date: July 20, 2017
    Inventors: Stephen COMISKEY, Rong FENG, John FOSS, Kunwar SHAILUBHAI
  • Publication number: 20170202903
    Abstract: The invention provides low-dose formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative.
    Type: Application
    Filed: March 23, 2017
    Publication date: July 20, 2017
    Inventors: Stephen COMISKEY, Rong FENG, John FOSS, Kunwar SHAILUBHAI
  • Patent number: 9711881
    Abstract: A tray used in a card connector for receiving a card therein includes a base having opposite top and bottom surfaces, a receiving room for receiving the card therein, and an inner surface surrounding the receiving room and connecting the top surface with the bottom surface. The base defines a plurality of thin portions projecting into the receiving room from the inner surface and a shallow notch recessed in the inner surface to adjacent to one of the plurality of thin portions, the shallow notch runs through both the top surface and the bottom surface. The present invention provides a low cost tray.
    Type: Grant
    Filed: August 31, 2016
    Date of Patent: July 18, 2017
    Assignee: FOXCONN INTERCONNECT TECHNOLOGY LIMITED
    Inventors: Zhan-Jun Xu, Fu-Jin Peng, Li-Jun Li, Fu-Rong Feng
  • Publication number: 20170129925
    Abstract: The invention provides processes of preparing a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-249 described herein.
    Type: Application
    Filed: January 13, 2017
    Publication date: May 11, 2017
    Applicant: Synergy Pharmaceuticals Inc.
    Inventors: Juncai Bai, Ruoping Zhang, Jun Jian, Junfeng Zhou, Qiao Zhao, Guoquing Zhang, Kunwar Shailubhai, Stephen Comiskey, Rong Feng
  • Patent number: 9616097
    Abstract: The invention provides low-dose formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative.
    Type: Grant
    Filed: March 15, 2012
    Date of Patent: April 11, 2017
    Assignee: SYNERGY PHARMACEUTICALS, INC.
    Inventors: Stephen Comiskey, Rong Feng, John Foss, Kunwar Shailubhai
  • Patent number: 9610321
    Abstract: The invention provides low-dose formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative.
    Type: Grant
    Filed: September 4, 2015
    Date of Patent: April 4, 2017
    Assignee: SYNERGY PHARMACEUTICALS, INC.
    Inventors: Stephen Comiskey, Rong Feng, John Foss, Kunwar Shailubhai
  • Publication number: 20170062958
    Abstract: A tray used in a card connector for receiving a card therein includes a base having opposite top and bottom surfaces, a receiving room for receiving the card therein, and an inner surface surrounding the receiving room and connecting the top surface with the bottom surface. The base defines a plurality of thin portions projecting into the receiving room from the inner surface and a shallow notch recessed in the inner surface to adjacent to one of the plurality of thin portions, the shallow notch runs through both the top surface and the bottom surface. The present invention provides a low cost tray.
    Type: Application
    Filed: August 31, 2016
    Publication date: March 2, 2017
    Inventors: ZHAN-JUN XU, FU-JIN PENG, LI-JUN LI, FU-RONG FENG
  • Patent number: 9580471
    Abstract: The invention provides processes of preparing a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-249 described herein.
    Type: Grant
    Filed: March 1, 2012
    Date of Patent: February 28, 2017
    Assignee: SYNERGY PHARMACEUTICALS, INC.
    Inventors: Juncai Bai, Ruoping Zhang, Jun Jia, Junfeng Zhou, Qiao Zhao, Guoquing Zhang, Kunwar Shailubhai, Stephen Comiskey, Rong Feng
  • Publication number: 20160145307
    Abstract: The invention provides processes of purifying a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-251 described herein. The processes include a solvent exchange step before a freeze-drying (lyophilization) step.
    Type: Application
    Filed: June 5, 2014
    Publication date: May 26, 2016
    Inventors: Kunwar SHAILUBHAI, Stephen COMISKEY, Rong FENG, Juncai BAI, Ruoping ZHANG, Jun JIA, Junfeng ZHOU, Qiao ZHAO, Guoqing ZHANG
  • Publication number: 20150366935
    Abstract: The invention provides low-dose formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative.
    Type: Application
    Filed: September 4, 2015
    Publication date: December 24, 2015
    Inventors: Stephen COMISKEY, Rong FENG, John FOSS, Kunwar SHAILUBHAI
  • Publication number: 20150336832
    Abstract: A sludge processing equipment includes a separation set, a mixer, a blower and a heat recovery unit. The mixer includes a mixing chamber, a feeder and an air compressor. The mixing chamber is communicated with the separation set. The feeder is configured to deliver a sludge into the mixing chamber. The air compressor is configured to provide a first compressed air to the feeder. The air compressor generates a wasted heat during operation. The blower is configured to provide a transporting airflow to the mixing chamber, so as to deliver the sludge to the separation set. The heat recovery unit is configured to deliver the wasted heat generated by the air compressor to the transporting airflow.
    Type: Application
    Filed: May 4, 2015
    Publication date: November 26, 2015
    Inventors: Rong-Feng TSAI, Chin-Te CHEN, Ming-Kuei CHIANG, Keng-Chuan SUNG
  • Patent number: 8847884
    Abstract: A method for offering services according to facial expressions is provided. The method has an electronic device storing a service database recording at least one user's information. The method activates an offering service function; captures facial expressions of the user; extracting the features of the facial expressions; compares the extracted features with the features in images of the facial expressions stored in the service database, so as to identify a corresponding feature stored in the service database, and determines the type of expression and the service corresponding thereto from images of the user stored in the service database; and activates and provides the determined service. An electronic device using the method is also provided.
    Type: Grant
    Filed: October 29, 2012
    Date of Patent: September 30, 2014
    Assignees: Hong Fu Jin Precision Industry (ShenZhen) Co., Ltd., Hon Hai Precision Industry Co., Ltd.
    Inventors: Hai-Sheng Li, Hui-Ling Ru, Rong-Feng Cheng, Chih-San Chiang